RT Journal Article
SR Electronic
T1 Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004822
DO 10.1136/jitc-2022-004822
VO 10
IS 5
A1 Raghav, Kanwal P
A1 Stephen, Bettzy
A1 Karp, Daniel D
A1 Piha-Paul, Sarina A
A1 Hong, David S
A1 Jain, Dipti
A1 Chudy Onwugaje, Dilichukwu O
A1 Abonofal, Abdulrahman
A1 Willett, Anneleis F
A1 Overman, Michael
A1 Smaglo, Brandon
A1 Huey, Ryan W
A1 Meric-Bernstam, Funda
A1 Varadhachary, Gauri R
A1 Naing, Aung
YR 2022
UL http://jitc.bmj.com/content/10/5/e004822.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.